Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study-Reference-Cited by-同舟云学术

Early discontinuation of DTG/ABC/3TC and BIC/TAF/FTC single-tablet regimens: a real-life multicenter cohort study

Published:2021-07-04 Issue:4 Volume:22 Page:96-101
ISSN:2578-7489
Container-title:HIV Research & Clinical Practice
language:en
Short-container-title:HIV Research & Clinical Practice

Author:

Lagi Filippo¹²^ORCID,Botta Annarita¹,Ciccullo Arturo³⁴^ORCID,Picarelli Chiara⁵,Fabbiani Massimiliano⁶,di Giambenedetto Simona³⁷,Borghi Vanni⁸,Mussini Cristina⁸,Bartoloni Alessandro¹²,Sterrantino Gaetana¹

Affiliation:

1. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

2. Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy

3. Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy

4. Gemelli Molise Hospital, Campobasso, Italy

5. IFO – Istituto Nazionale Tumori Regina Elena, Dermatologic Institute San Gallicano, Rome, Italy

6. UOC Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Senese, Siena, Italy

7. Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy

8. Infectious and Tropical Diseases Unit, Azienda Ospedaliero Universitaria di Modena, Modena, Italy

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/25787489.2021.1965757

Reference22 articles.

1. AIDS as a chronic illness: psychosocial implications

2. Switching regimens in virologically suppressed HIV‐1‐infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)‐containing regimens

3. Switching strategies in the recent era of antiretroviral therapy

4. Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients

5. Reduced risk of Efavirenz Discontinuation in Naïve Patients Starting First‐Line Antiretroviral Therapy with Single Tablet versus dual Tablet Regimen

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy;AIDS;2024-02-21

2. Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH);Infectious Disease Reports;2023-12-11

3. Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review;Expert Review of Anti-infective Therapy;2023-04-20

4. Central nervous system disorders in HIV-infected individuals using distinct antiretroviral drugs;Aids Reviews;2023-03-16

5. Comparison of Virological Efficacy of DTG/ABC/3TG and B/F/TAF Regimens and Discontinuation Patterns in Persons Living with Advanced HIV in the Era of Rapid ART: A Retrospective Multicenter Cohort Study;Infectious Diseases and Therapy;2022-12-15